Significance of aldo-keto reductase 1C3 and ATP-binding cassette transporter B1 in gain of irinotecan resistance in colon cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Significance of aldo-keto reductase 1C3 and ATP-binding cassette transporter B1 in gain of irinotecan resistance in colon cancer cells
Authors
Keywords
Aldo-keto reductase 1C3, Irinotecan, Chemoresistance, Colon cancer, ATP-Binding cassette B1, Pregnane-X receptor
Journal
CHEMICO-BIOLOGICAL INTERACTIONS
Volume 332, Issue -, Pages 109295
Publisher
Elsevier BV
Online
2020-10-20
DOI
10.1016/j.cbi.2020.109295
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reversal of Apalutamide and Darolutamide Aldo-Keto Reductase 1C3-Mediated Resistance by a Small Molecule Inhibitor
- (2020) Ahmed Morsy et al. ACS Chemical Biology
- Irinotecan Induces Autophagy-Dependent Apoptosis and Positively Regulates ROS-Related JNK- and P38-MAPK Pathways in Gastric Cancer Cells
- (2020) Qingyun Zhu et al. OncoTargets and Therapy
- Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells
- (2019) Toshiyuki Matsunaga et al. CHEMICO-BIOLOGICAL INTERACTIONS
- E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity
- (2018) Irina Druzhkova et al. Clinical Colorectal Cancer
- Pathophysiology of mitochondrial lipid oxidation: Role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria
- (2017) Mengqing Xiao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review
- (2017) Dorte Lisbet Nielsen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Controversy about pharmacological modulation of Nrf2 for cancer therapy
- (2017) Lidija Milkovic et al. Redox Biology
- 4-Hydroxy-2-nonenal: a critical target in oxidative stress?
- (2016) Mason Breitzig et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance
- (2016) Toshiyuki Matsunaga et al. FREE RADICAL RESEARCH
- Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines
- (2016) Kshitij Verma et al. ACS Medicinal Chemistry Letters
- Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells
- (2014) Toshiyuki Matsunaga et al. ANTI-CANCER DRUGS
- Pathophysiological roles of aldo–keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers
- (2012) Toshiyuki Matsunaga et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Somatic mutations of the KEAP1 gene in common solid cancers
- (2012) Nam Jin Yoo et al. HISTOPATHOLOGY
- Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibition
- (2012) Patrick A. Mayes et al. INTERNATIONAL JOURNAL OF CANCER
- Decreased expression of 17β-hydroxysteroid dehydrogenase type 1 is associated with DNA hypermethylation in colorectal cancer located in the proximal colon
- (2011) Agnieszka Anna Rawłuszko et al. BMC CANCER
- Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice
- (2011) Hongwei Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Overcoming drug resistance by regulating nuclear receptors
- (2010) Taosheng Chen ADVANCED DRUG DELIVERY REVIEWS
- Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma
- (2010) S. Paillas et al. CANCER RESEARCH
- Roles of rat and human aldo–keto reductases in metabolism of farnesol and geranylgeraniol
- (2010) Satoshi Endo et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): Overview and structural insights
- (2010) Michael C. Byrns et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
- (2010) Caroline Raynal et al. Molecular Cancer
- Steroid Sulfatase and Estrogen Sulfotransferase in Colon Carcinoma: Regulators of Intratumoral Estrogen Concentrations and Potent Prognostic Factors
- (2009) R. Sato et al. CANCER RESEARCH
- Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1–NRF2 pathway, and not the BACH1–NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds
- (2009) A.Kenneth MacLeod et al. CARCINOGENESIS
- Nrf2: friend or foe for chemoprevention?
- (2009) T. W. Kensler et al. CARCINOGENESIS
- Structure-Guided Design, Synthesis, and Evaluation of Salicylic Acid-Based Inhibitors Targeting a Selectivity Pocket in the Active Site of Human 20α-Hydroxysteroid Dehydrogenase (AKR1C1)
- (2009) Ossama El-Kabbani et al. JOURNAL OF MEDICINAL CHEMISTRY
- Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer
- (2009) Michael C. Byrns et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance
- (2009) Zachary W. Veitch et al. Pharmacogenetics and Genomics
- Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4
- (2008) Shu-Feng Zhou CURRENT DRUG METABOLISM
- The Aldo-Keto Reductase Superfamily and its Role in Drug Metabolism and Detoxification
- (2008) Oleg A. Barski et al. DRUG METABOLISM REVIEWS
- Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer
- (2008) Tina Šmuc et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started